SCHEMBL3334808

SCHEMBL3334808

Cc1cc(-c2cc(-c3ccc(N)cc3C)[nH]c(=O)n2)ccc1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 3/20 0.65
CDC7 O00311 8/20 0.65
GSK3B P49841 2/20 0.65
CSNK2A1 P68400 2/20 0.65
CSNK2A2 P19784 1/20 0.65
CLK1 P49759 1/20 0.65
CSNK2B P67870 1/20 0.65
CSNK2A3 Q8NEV1 1/20 0.65
CXCL12 P48061 1/20 0.48
PDE10A Q9Y233 1/20 0.45
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
FGFR1 P11362 2/20 0.36
MAPK13 O15264 1/20 0.36
DAPK3 O43293 1/20 0.36
ROCK2 O75116 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11915777 0.88 CDC7 (0.79) PIM1CDC7GSK3BCSNK2A1CSNK2A2
SCHEMBL12514208 0.87 CDC7 (0.66) PIM1CDC7GSK3BCSNK2A1CSNK2A2
SCHEMBL383935 0.86 PIM1 (0.65) PIM1CDC7GSK3BCSNK2A1CSNK2A2
SCHEMBL14547357 0.84 PIM1 (0.80) PIM1CDC7GSK3BCSNK2A1CSNK2A2
SCHEMBL3329659 0.81 PIM1 (0.56) PIM1CDC7GSK3BCSNK2A1CSNK2A2
SCHEMBL3331554 0.80 PDE10A (0.50) PIM1CDC7GSK3BCSNK2A1CSNK2A2
SCHEMBL386108 0.80 CDC7 (0.82) PIM1CDC7GSK3BCSNK2A1CSNK2A2
SCHEMBL385819 0.80 CDC7 (0.82) PIM1CDC7GSK3BCSNK2A1CSNK2A2
SCHEMBL383517 0.80 PIM1 (0.77) PIM1CDC7GSK3BCSNK2A1CSNK2A2
SCHEMBL3333095 0.79 PIM1 (0.54) PIM1CDC7GSK3BCSNK2A1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8242129-B2 6-phenylpyrimidinones as PIM modulators EXELIXIS, INC. (US) 2012-08-14 US disclosed
US-20100135954-A1 6-Phenylpyrimidinones as PIM Modulators EXELIXIS, INC. (US) 2010-06-03 US disclosed
EP-2074103-A1 6-PHENYLPYRIMIDINONES AS PIM MODULATORS Exelixis, Inc. (US) 2009-07-01 EP disclosed
WO-2008133955-A1 6-PHENYLPYRIMIDINONES AS PIM MODULATORS EXELIXIS, INC. (US) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100135954-A1 6-Phenylpyrimidinones as PIM Modulators PIM1, PIM2, PIM3 PIM1 1/4885CDC7 3813/4885GSK3B 907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.